Learn more

FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE UCHREZHDENIE NAUKI INSTITUT KHIM BIOLOGII I FUNDAMENTALNOJ ME

Overview
  • Total Patents
    20
  • GoodIP Patent Rank
    84,553
  • Filing trend
    0.0%
About

FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE UCHREZHDENIE NAUKI INSTITUT KHIM BIOLOGII I FUNDAMENTALNOJ ME has a total of 20 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2016. It filed its patents most often in Russian Federation. Its main competitors in its focus markets biotechnology, pharmaceuticals and organic fine chemistry are BEIJING PERCANS ONCOLOGY CO LTD, THE US SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES and HANGZHOU RONGZE BIOLOGICAL TECH CO LTD.

Patent filings in countries

World map showing FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE UCHREZHDENIE NAUKI INSTITUT KHIM BIOLOGII I FUNDAMENTALNOJ MEs patent filings in countries
# Country Total Patents
#1 Russian Federation 20

Patent filings per year

Chart showing FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE UCHREZHDENIE NAUKI INSTITUT KHIM BIOLOGII I FUNDAMENTALNOJ MEs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Rikhter Vladimir Aleksandrovich 7
#2 Kuligina Elena Vladimirovna 7
#3 Koval Olga Aleksandrovna 7
#4 Kulemzin Sergej Viktorovich 5
#5 Nushtaeva Anna Andreevna 5
#6 Taranin Aleksandr Vladimirovich 5
#7 Belovezhets Tatyana Nikolaevna 4
#8 Volkova Olga Yurevna 4
#9 Gorchakov Andrej Aleksandrovich 4
#10 Tkachenko Anastasiya Viktorovna 3

Latest patents

Publication Filing date Title
RU2726541C1 Recombinant human breast cancer cell line brcch4e-134, expressing human prostate-specific membrane antigen
RU2724431C1 Recombinant cyto-car-yt-lact cell line exhibiting high cytotoxic activity with respect to psca-positive human cancer cells
RU2730657C1 Anti-tumour agent based on recombinant vaccinia virus strain and method for production thereof
RU2717654C1 HUMAN BREAST CANCER CELL LINE BrCCh4e
RU2707922C1 Recombinant plasmid dna of pqe-30_p36gp12_gp57, providing synthesis of recombinant protein p36gp12 in cells of escherichia coli, a strain of bacteria escherichia coli - producer of recombinant protein p36gp12, recombinant protein p36gp12, capable to bind lipopolysaccharides escherichia coli
RU2699045C1 Method of modifying surface of biodegradable polymer materials
RU2693251C1 Method for extracting and purifying recombinant protein, an analogue of a human kappa-casein fragment having cytotoxic activity towards human cancer cells
RU2712901C1 Psca-car-yt cell line having surface expression of chimeric antigen receptors and exhibiting cytotoxic activity on psca-positive human cancer cells
RU2676897C1 Method for determination of mtdna share with deletions in biological samples
RU2682745C1 Combination of genes constitutively expressed in healthy and varicose veins
RU2683221C1 Recombinant el1 peptide having cytotoxic activity relative to human cancer cells
RU2669344C1 Method for producing a microfiber material releasing medicament
RU2661624C1 Method for treatment of irritable body syndrome
RU2644229C1 Rna-aptamer with ability to learnrecognize autoantibodies, characteristic for multiple sclerosis
RU2740501C2 Modified oligonucleotides which activate rnase h
RU2644280C1 Method of obtaining an antitumor congruit on the basis of human serum albumin containing therapeutic and contrast agents
RU2637637C1 Method for prediction of clinical course of acute pancreatitis
RU2637360C1 Method of dna purification from paraffin blocks with histological biomaterial
RU2635765C1 Means with antiviral activity against influenza virus
RU2646113C1 Method for making system of delivery of nucleic acid fragments to mammalian cells